Search
for
Sort by
Research 241–270 of 1000+
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Methotrexate in dermatology
- Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Telogen effluvium
- Androgen receptors and their biology
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- The role of lymphocytes in the development and treatment of alopecia areata
- Nanotechnology in Dermatology
- Bacteria induce skin regeneration via IL-1β signaling
- Genetic Defects in Human Pericentrin Are Associated With Severe Insulin Resistance and Diabetes
- Advances in the management of alopecia areata
- Oral Manifestations of Hematologic and Nutritional Diseases
- Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
- TOXIC EPIDERMAL NECROLYSIS
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Acquired scalp alopecia. Part I: A review
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Evidence-based approach to cutaneous hyperandrogenism in women
- A Mouse Model of Androgenetic Alopecia
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Redefining hormone resistance in prostate cancer
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Gender-Affirming Hormone Therapy for Transgender Females